Hair Loss in Men
-
Male Hair Loss Conditions
- Male Pattern Hair Loss
- Other Conditions
-
Male Hair Loss Treatments
- Hair Loss Treatments – A Guide
-
Patterns of Hair Loss
- Receding Hairline
- Thinning Crown
- General Thinning
-
Hair Loss Success Stories
- Hair Regrowth Photo-Gallery
Hair Loss in Women
-
Female Hair Loss Conditions
- Hair Loss in Women - Guide
- Female Pattern Hair Loss
- Telogen Effluvium (TE)
- Diffuse Thinning | Chronic TE
- Alopecia Areata
-
Female Hair Loss Treatments
- Female Hair Loss Treatments - A Guide
- Belgravia High-Strength Minoxidil
- Hair Vitalics For Women
- Clinical Treatment Therapy
-
Hair Loss Success Stories
- Women’s Hair Regrowth Photo-Gallery
Hair Loss in Men
-
Back
-
Male Hair Loss Conditions
- Male Pattern Hair Loss
- Other Conditions
-
Male Hair Loss Treatments
- Hair Loss Treatments – A Guide
-
Patterns of Hair Loss
- Receding Hairline
- Thinning Crown
- General Thinning
-
Hair Loss Success Stories
- Hair Regrowth Photo-Gallery
Hair Loss in Women
-
Back
-
Female Hair Loss Conditions
- Hair Loss in Women - Guide
- Female Pattern Hair Loss
- Telogen Effluvium (TE)
- Diffuse Thinning | Chronic TE
- Alopecia Areata
-
Female Hair Loss Treatments
- Female Hair Loss Treatments - A Guide
- Belgravia High-Strength Minoxidil
- Hair Vitalics For Women
- Clinical Treatment Therapy
-
Hair Loss Success Stories
- Women’s Hair Regrowth Photo-Gallery
LaserComb FDA Clearance Misconception
There seems to be a number of common misconceptions related to hair loss products, one of the most popular being the idea that the HairMax LaserComb has only been cleared by the FDA for safety, not effectiveness.
If you read the FDA clearance letter sent to HairMax (the manufacturers of the LaserComb) you will see that it clearly states ‘The LaserComb is indicated to promote hair growth in males with androgenetic alopecia who have Norwood Hamilton classification of IIa to V and Fitzpatrick skin types of I to IV.’ Here’s the FDA clearance letter.
HairMax carried out placebo-controlled clinical studies in order to prove the effectiveness of their device. Hopefully this information will clear this matter up. Here is a report related to a study carried out in 2014 - LaserComb Clinical Study.
If you read the FDA clearance letter sent to HairMax (the manufacturers of the LaserComb) you will see that it clearly states ‘The LaserComb is indicated to promote hair growth in males with androgenetic alopecia who have Norwood Hamilton classification of IIa to V and Fitzpatrick skin types of I to IV.’ Here’s the FDA clearance letter.
HairMax carried out placebo-controlled clinical studies in order to prove the effectiveness of their device. Hopefully this information will clear this matter up. Here is a report related to a study carried out in 2014 - LaserComb Clinical Study.
The Belgravia Centre
The Belgravia Centre is a world-renowned group of a hair loss clinic in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation from anywhere in the world for home-use treatment.
View our Hair Loss Success Stories, which includes the world's largest gallery of hair growth photos and demonstrates the level of success that so many of Belgravia's patients achieve.
Our customers say